Cysteine-Mediated Redox Regulation of Cell Signaling in Chondrocytes Stimulated with Fibronectin Fragments

Arthritis and Rheumatology

Volumn 68, Issue 1, 2016, Pages 117-126

  Wood, Scott T ^a   Long, David L ^b   Reisz, Julie A ^b   Yammani, Raghunatha R ^b   Burke, Elizabeth A ^b   Klomsiri, Chananat ^b   Poole, Leslie B ^b   Furdui, Cristina M ^b   Loeser, Richard F ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,5 DIMETHYL 1,3 CYCLOHEXANEDIONE; COLLAGENASE 3; CYSTEINE; FIBRONECTIN; PROTEIN TYROSINE KINASE; SULFENIC ACID DERIVATIVE; CYCLOHEXANONE DERIVATIVE; MMP13 PROTEIN, HUMAN; PEPTIDE FRAGMENT;

AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CATABOLISM; CELL LABELING; CELL LYSATE; CELL STIMULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; KNEE OSTEOARTHRITIS; MALE; OXIDATION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; SULFENYLATION; ADULT; CASE CONTROL STUDY; CHONDROCYTE; CYTOLOGY; DRUG EFFECTS; HISTORY; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; OXIDATION REDUCTION REACTION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; CHONDROCYTES; CYCLOHEXANONES; CYSTEINE; FEMALE; FIBRONECTINS; HISTORY, ANCIENT; HUMANS; IMMUNOBLOTTING; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 13; MICROSCOPY, CONFOCAL; MIDDLE AGED; OSTEOARTHRITIS; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SULFENIC ACIDS;

EID: 84952024552     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39326     Document Type: Article

References (54)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 2008; 58: 26-35.
2. Dunn JD, Pill MW., A claims-based view of health care charges and utilization for commercially insured patients with osteoarthritis. Manag Care 2009; 18: 44-50.
3. Loeser RF, Goldring SR, Scanzello CR, Goldring MB., Osteoarthritis: a disease of the joint as an organ [review]. Arthritis Rheum 2012; 64: 1697-707.
4. Lotz M, Loeser RF., Effects of aging on articular cartilage homeostasis. Bone 2012; 51: 241-8.
5. Ding L, Guo D, Homandberg GA., Fibronectin fragments mediate matrix metalloproteinase upregulation and cartilage damage through proline rich tyrosine kinase 2, c-Src, NF-κB and protein kinase Cδ. Osteoarthritis Cartilage 2009; 17: 1385-92.
6. Homandberg GA, Meyers R, Williams JM., Intraarticular injection of fibronectin fragments causes severe depletion of cartilage proteoglycans in vivo. J Rheumatol 1993; 20: 1378-82.
7. Xie DL, Meyers R, Homandberg GA., Fibronectin fragments in osteoarthritic synovial fluid. J Rheumatol 1992; 19: 1448-52.
8. Homandberg GA, Meyers R, Xie DL., Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 1992; 267: 3597-604.
9. Ding L, Guo D, Homandberg GA., The cartilage chondrolytic mechanism of fibronectin fragments involves MAP kinases: comparison of three fragments and native fibronectin. Osteoarthritis Cartilage 2008; 16: 1253-62.
10. Homandberg GA, Costa V, Wen C., Fibronectin fragments active in chondrocytic chondrolysis can be chemically cross-linked to the α5 integrin receptor subunit. Osteoarthritis Cartilage 2002; 10: 938-49.
11. Pulai JI, Chen H, Im HJ, Kumar S, Hanning C, Hegde PS, et al., NF-κB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 2005; 174: 5781-8.
12. Forsyth CB, Pulai J, Loeser RF., Fibronectin fragments and blocking antibodies to α2β1 and α5β1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 2002; 46: 2368-76.
13. Del Carlo M, Schwartz D, Erickson EA, Loeser RF., Endogenous production of reactive oxygen species is required for stimulation of human articular chondrocyte matrix metalloproteinase production by fibronectin fragments. Free Radic Biol Med 2007; 42: 1350-8.
14. Schroder K., NADPH oxidases in redox regulation of cell adhesion and migration. Antioxid Redox Signal 2014; 20: 2043-58.
15. Chung HS, Wang SB, Venkatraman V, Murray CI, van Eyk JE., Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ Res 2013; 112: 382-92.
16. Klomsiri C, Karplus PA, Poole LB., Cysteine-based redox switches in enzymes. Antioxid Redox Signal 2011; 14: 1065-77.
17. Poole LB, Karplus PA, Claiborne A., Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 2004; 44: 325-47.
18. Weerapana E, Wang C, Simon GM, Richter F, Khare S, Dillon MB, et al., Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 2010; 468: 790-5.
19. Roos G, Messens J., Protein sulfenic acid formation: from cellular damage to redox regulation. Free Radic Biol Med 2011; 51: 314-26.
20. Frijhoff J, Dagnell M, Godfrey R, Ostman A., Regulation of protein tyrosine phosphatase oxidation in cell adhesion and migration. Antioxid Redox Signal 2014; 20: 1994-2010.
21. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, et al., Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 2003; 161: 933-44.
22. Eble JA, de Rezende FF., Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins. Antioxid Redox Signal 2014; 20: 1977-93.
23. Giannoni E, Chiarugi P., Redox circuitries driving SRC regulation. Antioxid Redox Signal 2014; 20: 2011-25.
24. Paulsen CE, Carroll KS., Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem Rev 2013; 113: 4633-79.
25. Furdui CM., Poole LB., Chemical approaches to detect and analyze protein sulfenic acids. Mass Spectrom Rev 2014; 33: 126-46.
26. Yin W, Park JI, Loeser RF., Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-kinase-Akt and MEK-ERK MAPK signaling pathways. J Biol Chem 2009; 284: 31972-81.
27. Leahy DJ, Aukhil I, Erickson HP., 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 1996; 84: 155-64.
28. Garcia-Hernandez V, Flores-Maldonado C, Rincon-Heredia R, Verdejo-Torres O, Bonilla-Delgado J, Meneses-Morales I, et al., EGF regulates claudin-2 and -4 expression through STAT3 and Src in MDCK cells. J Cell Physiol 2015; 230: 105-15.
29. Lien GS, Wu MS, Bien MY, Chen CH, Lin CH, Chen BC., Epidermal growth factor stimulates nuclear factor-κB activation and heme oxygenase-1 expression via c-Src, NADPH oxidase, PI3K, and Akt in human colon cancer cells. PLoS One 2014; 9: e104891.
30. Yang J, Gupta V, Carroll KS, Liebler DC., Site-specific mapping and quantification of protein S-sulphenylation in cells. Nat Commun 2014; 5: 4776.
31. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, et al., The selectivity of protein kinase inhibitors: a further update. Biochem J 2007; 408: 297-315.
32. Long D, Blake S, Song XY, Lark M, Loeser RF., Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13. Arthritis Res Ther 2008; 10: R23.
33. Loeser RF, Forsyth CB, Samarel AM, Im HJ., Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem 2003; 278: 24577-85.
34. Reisz JA, Bechtold E, King SB, Poole LB, Furdui CM., Thiol-blocking electrophiles interfere with labeling and detection of protein sulfenic acids. FEBS J 2013; 280: 6150-61.
35. Klomsiri C, Nelson KJ, Bechtold E, Soito L, Johnson LC, Lowther WT, et al., Use of dimedone-based chemical probes for sulfenic acid detection evaluation of conditions affecting probe incorporation into redox-sensitive proteins. Methods Enzymol 2010; 473: 77-94.
36. Nelson KJ, Klomsiri C, Codreanu SG, Soito L, Liebler DC, Rogers LC, et al., Use of dimedone-based chemical probes for sulfenic acid detection methods to visualize and identify labeled proteins. Methods Enzymol 2010; 473: 95-115.
37. Maller C, Schroder E, Eaton P., Glyceraldehyde 3-phosphate dehydrogenase is unlikely to mediate hydrogen peroxide signaling: studies with a novel anti-dimedone sulfenic acid antibody. Antioxid Redox Signal 2011; 14: 49-60.
38. Schneider CA, Rasband WS, Eliceiri KW., NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-5.
39. Huang LK, Wang MJ., Image thresholding by minimizing the measures of fuzziness. Pattern Recognit 1995; 28: 41-51.
40. Wang Y, Botvinick EL, Zhao Y, Berns MW, Usami S, Tsien RY, et al., Visualizing the mechanical activation of Src. Nature 2005; 434: 1040-5.
41. Vilela M, Halidi N, Besson S, Elliott H, Hahn K, Tytell J, et al., Fluctuation analysis of activity biosensor images for the study of information flow in signaling pathways. In:, Tetin SY, editor. Fluorescence fluctuation spectroscopy. San Diego: Elsevier Academic Press; 2013. p. 253-76.
42. Li CH, Tam PK., An iterative algorithm for minimum cross entropy thresholding. Pattern Recognit Lett 1998; 19: 771-6.
43. Chiarugi P., Src redox regulation: there is more than meets the eye. Mol Cells 2008; 26: 329-37.
44. Del Carlo M Jr, Loeser RF., Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels. Arthritis Rheum 2003; 48: 3419-30.
45. Kheradmand F, Werner E, Tremble P, Symons M, Werb Z., Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 1998; 280: 898-902.
46. Homandberg GA, Hui F, Wen C., Fibronectin fragment mediated cartilage chondrolysis. I. Suppression by anti-oxidants. Biochim Biophys Acta 1996; 1317: 134-42.
47. Wani R, Qian J, Yin L, Bechtold E, King SB, Poole LB, et al., Isoform-specific regulation of Akt by PDGF-induced reactive oxygen species. Proc Natl Acad Sci U S A 2011; 108: 10550-5.
48. Lo YY, Cruz TF., Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 1995; 270: 11727-30.
49. Forsyth CB, Cole A, Murphy G, Bienias JL, Im HJ, Loeser RF Jr., Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. J Gerontol A Biol Sci Med Sci 2005; 60: 1118-24.
50. Kelly GS., Clinical applications of N-acetylcysteine. Altern Med Rev 1998; 3: 114-27.
51. Kaplan KB, Swedlow JR, Morgan DO, Varmus HE., c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism. Genes Dev 1995; 9: 1505-17.
52. -/- mutant mice. Genes Dev 1997; 11: 2835-44.
53. Garcia-Martinez JM, Calcabrini A, Gonzalez L, Martin-Forero E, Agullo-Ortuno MT, Simon V, et al., A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling. Cell Signal 2010; 22: 415-26.
54. Kaplan KB, Bibbins KB, Swedlow JR, Arnaud M, Morgan DO, Varmus HE., Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. EMBO J 1994; 13: 4745-56.